Josh Mandel-Brehm, Camp4 Therapeutics CEO (Camp4)
Going after the phenomenon of 'regRNA,' Rick Young's Camp4 secures a launch round to push two programs forward
You’ve heard of mRNA, largely thanks to the Covid-19 vaccines developed by Pfizer/BioNTech and Moderna. If you watch the R&D space closely, you’ve also probably …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
